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Abstract
Background: Within an enhanced recovery pathway (ERP), the approach to treating pain should be multifaceted
and the goal should be to deliver “optimal analgesia,” which we define in this paper as a technique that optimizes
patient comfort and facilitates functional recovery with the fewest medication side effects.
Methods: With input from a multi-disciplinary, international group of clinicians, and through a structured review of
the literature and use of a modified Delphi method, we achieved consensus surrounding the topic of optimal
analgesia in the perioperative period for colorectal surgery patients.
Discussion: As a part of the first Perioperative Quality Improvement (POQI) workgroup meeting, we sought to
develop a consensus document describing a comprehensive, yet rational and practical, approach for developing an
evidence-based plan for achieving optimal analgesia, specifically for a colorectal surgery ERP. The goal was two-fold:
(a) that application of this process would lead to improved patient outcomes and (b) that investigation of the
questions raised would identify knowledge gaps to aid the direction for research into analgesia within ERPs in the
years to come. This document details the evidence for a wide range of analgesic components, with particular focus
from the preoperative period to the post-anesthesia care unit. The overall conclusion is that the combination of
analgesic techniques employed in the perioperative period is not important as long as it is effective in delivering
the goal of optimal analgesia as set forth in this document.
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Introduction
Pain after major abdominal surgery is severe and is a
major component of the stress response if not adequately
treated (Schricker and Lattermann 2015). Pain is triggered
as a combination of neural and inflammatory pathways
with injury to the viscera, muscle, and skin. The intensity
and duration of each of these triggers varies according to
the type of surgical procedure performed and which surgi-
cal approach is used (laparoscopic, robotic assisted, or
open) (Reza et al. 2006). Additionally, patients respond
differently to pain in the perioperative period and patients
with chronic pain conditions often experience a greater
amount of suffering in the immediate perioperative
period. Thus, it is not only important to treat pain effect-
ively from a humane point of view but also because this is
a major factor in reducing the stress response to surgery
and restoring function thereafter.
The concept of an enhanced recovery pathway (ERP)
is a multi-component approach aimed at reducing the
stress of surgery experienced by the patient, improving
the metabolic response, and thereby speeding the return
of functional recovery (Kehlet and Wilmore 2008).
Within an ERP, the approach to treating pain should be
multifaceted, including a combination of techniques
such as neural blockade, intravenous, and multimodal
oral analgesia. The goal should be to deliver “optimal
analgesia,” which we define in this paper as a technique
that optimizes patient comfort and facilitates functional
recovery with the fewest medication side effects (see
Fig. 1). Of note, this may not correspond with the lowest
pain perception possible. Overall, the combination of an-
algesic techniques employed is not important as long as
it is effective in delivering this goal of optimal analgesia.
As a part of the first Perioperative Quality Improvement
(POQI) workgroup meeting, we sought to develop a
consensus document addressing these questions. Our
intent was to develop a comprehensive, yet rational
and practical, approach for developing an evidence-
based plan for achieving optimal analgesia specifically
for a colorectal surgery (CRS) ERP. The goal would
be two-fold: (a) that application of this process would
lead to improved patient outcomes and (b) that inves-
tigation of the questions raised would identify know-
ledge gaps to aid the direction for research into
analgesia within ERPs in the years to come. The over-
all vision for our working group was to encourage
rigorous development and application of evidence-
based perioperative medicine related to achieving op-
timal analgesia for patients undergoing CRS.
Methods
We used the Delphi method to achieve consensus
surrounding the topic of optimal analgesia in the peri-
operative period for colorectal surgery patients. The
Delphi method has been used in various formats to ob-
tain the perspectives and opinions of diverse groups.
The participants in the POQI consensus meeting in-
cluded anesthesiologists, surgeons, and nurses who
were recruited based on their expertise in the principles
of enhanced recovery after surgery and perioperative
medicine. For our use, the process included several
iterative steps, including building consensus around the
important questions related to the topic, a literature
review of the topics, and sequential steps of content
building and refinement until agreement is achieved
and a consensus document is produced.
Fig. 1 The core components of providing optimal analgesia. Pain after surgery can have profound effects on patient recovery. However, the
complete elimination of pain may also have untoward effects, as listed in the figure. Optimal analgesia after surgery is an approach to pain
control that facilitates a positive patient experience through optimized patient comfort that facilitates functional recovery while minimizing
adverse drug events
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Expert group and process
A group of international experts was established, includ-
ing viewpoints representing anesthesiology, surgery, and
nursing. In this POQI I subgroup, each expert was re-
quired to submit questions related to optimal periopera-
tive analgesia within ERPs. This first project specifically
focused on colorectal surgery patients. Questions were
then shared among the group for commentary and elab-
oration. A final list of questions was agreed upon by the
end of the 2-day conference after undergoing a four-step
modified Delphi process (Miller et al. 2016).
For content to be included in the paper, we searched
PubMed from 1966 to April 2016. All co-authors were
familiar with proper literature search protocols, and each
conducted a search for at least one portion of the consen-
sus document and shared those references with the other
experts. The search was limited to human trials but not
limited by language. Duplicate records were deleted. The
authors screened the search results in a stepwise manner
to identify the eligible studies. In the first step, we
screened the titles and abstracts, and irrelevant papers
were excluded. During the POQI I conference and there-
after as a writing group, reference applicability to the topic
was discussed in any area where there was disagreement.
Results
Our group arrived at the following list of questions as
being those most pertinent to and all-encompassing of
the topic of optimal analgesia as a component of an ERP
for CRS:
1. What is the definition of optimal analgesia for
colorectal surgery?
2. Why should opioid use be minimized for colorectal
surgery patients?
3. How can optimal analgesia be achieved whilst
minimizing opioid use in the preoperative and
intraoperative period for colorectal surgery?
4. How does pain vary based upon the surgical
approach in colorectal surgery?
5. What strategies lead to successful implementation
of optimal analgesia for colorectal surgery?
Q1: What is the definition of optimal analgesia for
colorectal surgery?
Statement: Optimal analgesia can be defined as a tech-
nique that optimizes patient comfort and facilitates
recovery of physical function including the bowel,
mobilization, cough and normal sleep, while minimizing
adverse effects of analgesics (see Fig. 1).
Optimal analgesia cannot be defined by simple pain
intensity ratings. Although pain intensity ratings have
been associated with impairments in function, there is a
nonlinear relationship between types of treatment,
analgesic doses, and changes in self-reported numeric
pain ratings (de C Williams et al. 2000). Pain after sur-
gery is rarely completely avoided, so “pain free” is not
the primary goal of optimal analgesia. Additionally, pain
over hours to days after surgery is a dynamic state that
is influenced by activities such as coughing and ambula-
tion, and thus a pain-free state is difficult to attain and
sustain without medication side effects. Accordingly, the
goal of pain prevention and treatment is to reduce pain
interference on surgical recovery to the greatest degree
possible and avoid secondary adverse outcomes evoked
by inflammation, the stress response, and immobilization;
hence, the emphasis of optimal analgesia on patient com-
fort combined with considerations of physical function,
sleep, side effects, and safety.
Q2: Why should opioid use be minimized for colorectal
surgery patients?
Statement: Minimizing opioid analgesia for CRS patients
reduces the adverse effects of opioid use.
There are some clear governing principles that can
guide pain management planning to minimize opioid
use, and, as discussed above, numerous interventions
exist to aid in this approach while optimizing periopera-
tive analgesia. However, opioids have been the backbone
for treating perioperative pain and are still used exten-
sively, if not exclusively, in most surgical specialties. As
such, it should be noted that the short-term side effects
of opioids including nausea, vomiting, ileus, urinary re-
tention, and somnolence can delay enteral intake and
mobilization, cause patient distress, and delay hospital
discharge in the colorectal surgical patient. Additionally,
postoperative delirium in the elderly is a frequent com-
plication that delays discharge and can be caused both
by uncontrolled pain and its treatment with opioids
(Oresanya et al. 2014; Bilotta et al. 2013; Leung et al.
2013). Finally, traditional use of an opioid-based pain
management regimen is likely to be associated with
developing hyperalgesia, whereas the use of non-opioid
approaches may result in reduced chronic postsurgical
pain, cancer recurrence, and long-term survival (Hayhurst
and Durieux 2016; Maher and White 2016). This has led
to the adoption of a multifaceted approach using various
analgesic components to greatly reduce the need to give
any opioids during the perioperative period. For all the
reasons detailed above, opioid-sparing pathways should be
considered a best practice.
Q3: How can optimal analgesia be achieved while
minimizing opioid use in the preoperative and
intraoperative period for colorectal surgery?
Statement: Optimal analgesia after CRS is achieved
through a planned multimodal analgesia approach minim-
izing opioid use during all phases of perioperative care.
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In order to deliver optimal analgesia, a well-structured
and planned multimodal approach should be constructed
that spans from the preoperative period into the post-
discharge recovery phase (see Fig. 2). The components of
such a plan will be discussed in detail in this manuscript.
It should be noted that there are numerous successful
ERPs for CRS with similar but varying analgesic compo-
nents represented in Fig. 2 (Thiele et al. 2015; Miller et al.
2014; Larson et al. 2014; McEvoy et al. 2016). What is
known is that reducing opioid use is of benefit, and high
compliance with a variety of standardized non-opioid ERP
bundles is strongly associated with reduced opioid use and
improved outcomes. In this document, we will restrict the
discussion to preoperative and intraoperative components.
Part 2 will discuss the analgesic approach throughout all
phases of postoperative care (Scott et al. 2016).
Preoperative interventions
Neural blockade Use of a single-shot spinal opioid (i.e.,
morphine or hydromorphone) is associated with signifi-
cantly lower pain at rest and on movement, and reduced
opioid requirements (Meylan et al. 2009). These benefits
are more prominent in patients undergoing abdominal
versus other types of surgery (e.g., cardiac). Although
the dose range for this meta-analysis varies considerably
(dose range, 100–4000 mcg), current practice tends
toward using lower doses of intrathecal morphine
(<0.3 mg) as higher dose of intrathecal morphine are as-
sociated with more episodes of respiratory depression
(Gehling and Tryba 2009). Some centers use a spinal
dose of bupivacaine as a carrier for the opioid to cover
the incision although there is often a resulting sympa-
thetic block.
Use of thoracic epidural anesthesia (TEA) for open
CRS is associated with superior postoperative analgesia
(Werawatganon and Charuluxanun 2005; Block et al.
2003), decreased pulmonary/cardiac morbidity (Popping
et al. 2014), and earlier return of gastrointestinal func-
tion as compared to parenteral analgesia (Marret et al.
2007; Hughes et al. 2014). However, the overall benefits
of TEA in improving recovery or decreasing length of
stay in patients undergoing laparoscopic colorectal
procedures are uncertain (Liu et al. 2014; Khan et al.
2013). Concern that prolonged sympathetic blockade
in TEA requires patients to have further intravenous
fluids to maintain intravascular volume in face of
arterial hypotension were not observed in one meta-
analysis of TEA versus patient-controlled analgesia
(PCA) in laparoscopic colectomy (Liu et al. 2014).
Peripheral blocks: truncal, paravertebral, and surgical
site Peripheral regional analgesia options for CRS
patients include transversus abdominis plane (TAP),
paravertebral, or wound and peritoneal infiltration blocks/
catheters. All have been shown to some extent to improve
perioperative analgesia while decreasing opioid use. Para-
vertebral blocks and catheters for surgical anesthesia at
the level of the thoracic and lumbar vertebrae are
Fig. 2 Suggested components of a multimodal approach to pain management in an ERP for colorectal surgery. Of note, the plan should be
comprehensive, encompassing all phases of perioperative care from preoperative to post-discharge. However, current evidence is insufficient to
determine how many components should be selected in order to maximize pain control, reduce opioid burden, and avoid the side effects of all
analgesics used. (ERP enhanced recovery pathway)
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associated with less pain during the immediate postopera-
tive period (Thavaneswaran et al. 2010).
Multiple meta-analyses indicate that TAP blocks/
catheters for abdominal surgical procedures are associ-
ated with superior analgesia and decreased postoperative
opioid consumption compared to opioid analgesia alone
(Baeriswyl et al. 2015; Zhao et al. 2014; Johns et al. 2012;
Siddiqui et al. 2011; Charlton et al. 2010). Preoperative
(vs. postoperative) TAP block administration appears to
have greater effects on early pain and opioid consump-
tion compared with postoperative administration al-
though the effect of preoperative (vs. postoperative) TAP
blocks on longer-term outcomes is unknown (De Oliveira
et al. 2014). TAP blocks provide comparable short-term
analgesia to wound infiltration but provide superior anal-
gesia in longer term and in the setting of a multimodal
analgesic regimen (Yu et al. 2014; Guo et al. 2015a).
Concerning the choice of local anesthetic, ropivacaine,
bupivacaine, and liposomal bupivacaine have all been
used in ERPs with good results (Hamada et al. 2016;
Cohen 2012). Liposomal bupivacaine shows some
promise for longer-term postoperative analgesia either
as infiltration or for TAP blocks (Hutchins et al.
2015); however, there are no large-scale randomized
controlled trials available in intra-abdominal surgery to
guide practice or to definitively demonstrate the anal-
gesic efficacy of this intervention (Cohen 2012; Candiotti
et al. 2014). In short, while there is insufficient evidence to
recommend one medication over another at this point in
time, it should be noted that additives, such as dexa-
methasone, are needed to prolong the duration of non-
liposomal mixtures (Akkaya et al. 2014).
Intraperitoneal instillation of local anesthetics dur-
ing major abdominal surgery, including open and lap-
aroscopic colectomy, is associated with significantly
lower pain scores postoperatively; although one study
did continue TEA in addition to intraperitoneal instil-
lation for 2 days after surgery (Marks et al. 2012;
Kahokehr et al. 2011; Park et al. 2011). Additionally,
wound infiltration has been shown to be associated
with a decrease in morphine consumption and signifi-
cantly lower pain scores in the early postoperative
period in abdominal surgery patients, but none specif-
ically in colorectal surgery (Bamigboye and Hofmeyr
2009). A meta-analysis suggested that the use of local
anesthetic wound infiltration was associated with pain
scores comparable to those obtained with epidural an-
algesia and a slight decrease in opioid use, although
the data was noted to be quite heterogeneous and signifi-
cance might exist in the patients receiving each treatment
(Ventham et al. 2013). The analgesic efficacy of local
anesthetic infusion through wound catheters is uncertain,
and meta-analyses have been conflicting in CRS (Liu et al.
2006; Gupta et al. 2011).
Oral analgesia Major non-opioid oral analgesic agents in-
clude non-steroidal anti-inflammatory agents (NSAIDs),
acetaminophen (paracetamol), gabapentinoids (gabapentin
and pregabalin), and tramadol. All except oral tramadol have
been examined within the setting of intra-abdominal surgery
and have been found to have significant effect on reducing
the opioid burden postoperatively. As such, routine, sched-
uled use of these agents should be considered as part of a
plan to achieve optimal analgesia after colorectal surgery.
Acetaminophen (paracetamol)
Acetaminophen (paracetamol) when administered as
part of a multimodal regimen is associated with a de-
crease in pain and decrease in opioid usage, which may
result in a decrease in some opioid-related side effects
(Doleman et al. 2015; De Oliveira et al. 2015; Wong et
al. 2013; Apfel et al. 2013; McNicol et al. 2011; Toms et
al. 2008; Remy et al. 2005). A single dose of IV acet-
aminophen (paracetamol), typically in a dose of 1 g,
given prior to surgery (meta-analysis of 11 RCTs of 740
patients) was associated with significantly lower early
pain at rest, early pain with movement, postoperative
opioid consumption, and postoperative nausea and
vomiting (De Oliveira et al. 2015). In a meta-analysis of
7 RCTs (n = 544 participants), 1 g or 15 mg/kg of IV
acetaminophen (paracetamol) given 10–30 min before
induction/incision (vs. the same dose given 10–30 min
at the end of surgery/before skin closure) was associated
with a reduction in 24-h opioid consumption and a
lower incidence of postoperative vomiting in the pre-
ventive acetaminophen (paracetamol) group (Doleman
et al. 2015). Most studies including pharmacokinetic
outcomes reported higher postoperative plasma concen-
trations and larger proportions of patients achieving
target plasma concentrations after IV dosing compared
with oral dosing (Jibril et al. 2015). However, for patients
who can take oral medications preoperatively, there does
not appear to be evidence of a clear benefit of the intra-
venous formulation. Decision making should take into
account of convenience and cost (Jibril et al. 2015).
Non-steroidal anti-inflammatory drugs
NSAIDs, whether non-selective or cyclooxygenase-2
inhibitors (COX-2), when administered as part of a
multimodal regimen, are associated with a decrease in
pain and decrease in opioid usage which may result in a
decrease in some opioid-related side effects (De Oliveira
et al. 2012; Marret et al. 2005; Straube et al. 2005;
Maund et al. 2011; Michelet et al. 2012; Elia et al. 2005).
Use of COX-2 inhibitors has minimal effect on coagula-
tion even at supra-therapeutic doses (Leese et al. 2000).
A systematic review noted that preoperative COX-2
inhibitors significantly reduced postoperative pain, anal-
gesic consumption, and antiemetic use, and improved
patients satisfaction compared with preoperative placebo
(Straube et al. 2005). In the studies examining celecoxib,
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the doses used were 200 or 400 mg PO, and for parecoxib,
they were 40 mg PO [Pandazi, 2010].
It is uncertain whether the perioperative use of
NSAIDs carries a risk of harm. While it is unlikely that
NSAIDs increase the risk of renal injury in euvolemic
patients who do not have contraindications to receiving
these medications (Myles and Power 1998), caution
should be undertaken in patients who are hypotensive or
thought to be hypovolemic. Additionally, there is a con-
cern for the potential for an association with increased
anastomotic leak, but the literature surrounding this
question is not conclusive. As such, insufficient evidence
is available to recommend against routine use of
NSAIDs, especially COX-2 inhibitors, as these medica-
tions are effective in treating pain and reducing opioid
use in the perioperative period (Chou et al. 2016a;
Bhangu et al. 2014).
Gabapentinoids
Several meta-analyses including studies concerning
intra-abdominal surgery suggest that gabapentinoids
(gabapentin, pregabalin) when given as a single dose pre-
operatively are associated with a decrease in postopera-
tive pain and opioid consumption at 24 h (Engelman
and Cateloy 2011; Eipe et al. 2015; Hurley et al. 2006;
Mishriky et al. 2015; Peng et al. 2007; Seib and Paul
2006; Zhang et al. 2011). For gabapentin, a preoperative
dose of 300–1200 mg is associated with lower pain
scores (both at rest and with movement) and reduced
opioid consumption (Hurley et al. 2006; Peng et al.
2007; Seib and Paul 2006). It should be noted that one
small RCT found that a single preoperative dose of gaba-
pentin 600 mg PO did not significantly reduce opioid
consumption or pain scores on POD 1 or 2 for patients
presenting for colectomy (Siddiqui et al. 2014). However,
opioid consumption and pain scores were lower at all
time points in the gabapentin group compared to pla-
cebo, but there were only 36 patients per group and it
was underpowered to detect any difference. As noted by
the authors, continuing doses in the postoperative
period may confer added benefit given the pharmacokin-
etics of gabapentin. This corresponds with the dosing
reported in successful ERPs for CRS where gabapentin is
used as one component to reduce opioid consumption
in the perioperative period (Larson et al. 2014; McEvoy
et al. 2016). However, the exact contribution of gabapen-
tin to these positive outcomes is unknown. For pregaba-
lin, a recent meta-analysis indicated that pain scores at
rest were reduced with all doses of pregabalin (mostly
75–300 mg) but pain scores with movement were only
reduced with the 300 mg dose and there were no signifi-
cant differences in side effects between the three dose
levels of pregabalin. The opioid-sparing effect of prega-
balin appeared to be limited to doses 100–150 and
300 mg but not ≤75 mg at 2 h after surgery (Mishriky et
al. 2015). While most of the studies in the meta-analysis
involve abdominal hysterectomy and cholecystectomy,
none were in CRS patients. Of note, there is a substan-
tial cost difference at present between gabapentin and
pregabalin. As such, if a gabapentinioid is to be consid-
ered as one component in an ERP, we recommend use
of gabapentin as a first line agent unless the patient was
prescribed pregabalin for a chronic pain condition prior
to surgery or if gabapentin use resulted in significant
sedation.
Intraoperative
Intravenous medications
Lidocaine
Intravenous (IV) lidocaine infusion is indicated as part
of a multimodal analgesic approach for visceral surgery
when other local anesthetic approaches such as regional
analgesia are not possible. In open and laparoscopic ab-
dominal surgery, IV lidocaine infusions have been shown
to result in significant reduction in postoperative pain
intensity at rest and with cough and movement and opi-
oid consumption for up to 48 h postoperatively, as well
as being associated with earlier return of bowel function
allowing for earlier recovery and shorter length of stay
(Marret et al. 2008; Vigneault et al. 2011). Lidocaine in-
fusions are contraindicated in patients with cardiovascu-
lar instability and concomitant use of alpha agonists or
beta-blockers and in patients with allergies to other
amide local anesthetics (bupivacaine). Side effects are
more pronounced in patients with liver dysfunction,
pulmonary diseases when the predominant problem is
carbon dioxide retention, and congestive heart failure.
Lidocaine is typically administered as a bolus (100–
150 mg or 1.5–2.0 mg/kg) followed by an infusion of 1
to 3 mg/kg/h through the end of surgery. Several meta-
analyses suggest that perioperative administration of IV
lidocaine is associated with a decrease in postoperative
pain and opioid consumption and possibly faster return
of bowel function and decreased length of hospital stay
(Marret et al. 2008; Vigneault et al. 2011; Khan et al.
2016; McCarthy et al. 2010).
N-methyl-D-aspartate antagonists
Ketamine. Perioperative inhibition of N-methyl-D-as-
partate (NMDA) receptors with clinically available
NMDA antagonists such as ketamine may be associated
with improved perioperative pain and decreased opioid
use (Wang et al. 2016; Ding et al. 2014; Dahmani et al.
2011; Bell et al. 2006). Perioperative ketamine, including
boluses as well as intraoperative and postoperative low-
dose infusions for up to 48 h, has been shown to result
in significant reductions in pain, opioid consumption,
and PONV with no significant side effect profile (Zakine
et al. 2008; Laskowski et al. 2011; Sami Mebazaa et al.
2008). The intraoperative boluses ranged from 0.15 to
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1 mg/kg, and perioperative infusions ranged from 1 to
5 mcg/kg/min, with a postoperative infusion rate of
2 mcg/kg/min. Ketamine has also been shown to be of
particular benefit in patients on chronic opioid, but this
has not been specifically tested in chronic pain patients
undergoing CRS (Loftus et al. 2010).
Magnesium. Systemic infusions of perioperative mag-
nesium may reduce postoperative pain and opioid con-
sumption (De Oliveira et al. 2013; Guo et al. 2015b;
Murphy et al. 2013). The optimal dosing is uncertain as
some studies include both a bolus followed by an infu-
sion whereas others only utilize an infusion without a
loading bolus. Typical boluses are 30–50 mg/kg, and the
infusion rates range from 4 to 15 mg/kg/h. None of the
studies in a systematic review reported clinical toxicity
related to toxic serum levels of magnesium (De Oliveira
et al. 2013).
Glucocorticoids
Glucocorticoid steroids may have analgesic properties
possibly related to anti-inflammatory properties and
should be considered as part of a multimodal periopera-
tive pain regimen. Several meta-analyses examined peri-
operative dexamethasone and indicated that patients
who received dexamethasone (4–10 mg or >0.1 mg/kg)
had lower pain scores, used less opioids, and required
less rescue analgesia (Waldron et al. 2013; Allen et al.
2012; De Oliveira et al. 2011). The concern for signifi-
cant hyperglycemia (>180 mg/dL) has not been con-
firmed, even in bariatric patients receiving these doses of
dexamethasone (Hans et al. 2006).
Alpha-2 agonists
A Cochrane review of dexmedetomidine infusions for
pain found reduced opioid consumption but no significant
difference in pain scores compared to placebo, and there
was more hypotension in the dexmedetomidine group
(Jessen Lundorf et al. 2016). Dexmedetomidine has been
added both perineurally to nerve blocks and intravenously
to prolong nerve block (Abdallah et al. 2016; Das et al.
2016). There is limited data, but dexmedetomidine does
appear to prolong nerve blocks. However, the extended
duration is not as long as that provided by perineural
dexamethasone provides. In a recent extensive review of
perioperative alpha agonists, dexmedetomidine and cloni-
dine were compared (Blaudszun et al. 2012). Similar to
dexmedetomidine, clonidine can also reduce opioid con-
sumption. In addition, both alpha agonists appear to have
a weak antiemetic effect, but as expected, both drugs had
adverse effects on hemodynamics. In summary, both dex-
medetomidine and clonidine when administered perio-
peratively can reduce morphine consumption up to 24 h
and to a similar extent as acetaminophen (paracetamol),
but not as much as other NSAIDs. Both clonidine
and dexmedetomidine have other side effects such as
sedation and hypotension that have to be considered
(Garg et al. 2014). Typical doses of clonidine range
from 1 to 5 mcg/kg PO, IV, or perineurally and for dexme-
detomidine from 0.5 mcg/kg IV bolus followed by an infu-
sion of 0.2–0.7 mcg/kg/h or 0.5 mcg/kg perineurally.
Acetaminophen (paracetamol)
If oral acetaminophen (paracetamol) is administered
preoperatively as part of a multimodal analgesia path-
way, there is typically no need to administer it again
until the next scheduled dose. If the next scheduled dose
is possible orally, then administration should be oral.
However, if the preoperative dose has been missed or
oral administration is not possible when the next dose is
due, then intravenous acetaminophen (paracetamol) can
be administered. Currently, there is no evidence that
intravenous acetaminophen (paracetamol) is superior to
oral formulations as an analgesic (Jibril et al. 2015; Fenlon
et al. 2013). If a patient is not able to take oral medica-
tions, then intravenous acetaminophen (paracetamol) has
been shown to be an effective opioid-sparing analgesic
compared to placebo (O’Neal 2013; Smith 2011).
Non-steroidal anti-inflammatory drugs
As noted above, NSAIDs should be prescribed or-
ally as part of routine preoperative medications for
colorectal surgery. However, if a preoperative dose is
not given for concerns of bleeding, parenteral options
are available. Ketorolac has been used extensively, and
newer preparations including intravenous ibuprofen
and diclofenac are now available (De Oliveira et al.
2012; Kroll 2012). These medications can improve
pain scores, reduce opioid requirements, and reduce
opioid-related side effects as discussed in the section
above. The optimal dose and timing of each of these
medications is not yet known. There is currently no
evidence of a better risk benefit profile for one intra-
venous NSAID over another.
Tramadol
Overall, there is limited evidence for the use of trama-
dol in colorectal surgery. However, one study in particu-
lar compared postoperative pain control with an opioid
IV-PCA to IV tramadol and found that the patients in
the non-PCA (tramadol) group needed less rescue anal-
gesia and none of them needed to have an IV-PCA
started (Choi et al. 2015). Additionally, another study in-
cluded scheduled tramadol as part of an ERP (Lloyd et
al. 2010). While this was only one component of the
ERP, overall pain scores and other outcomes were im-
proved. If tramadol is to be used, one study would sug-
gest caution with its use in patients undergoing major
abdominal surgery who are over 75 years, ASA 3 or 4,
and have impaired mobility or frailty, as use in this set-
ting was associated with delirium (Brouquet et al. 2010).
Based on the evidence that exists in colorectal surgery,
we recommend considering tramadol as an analgesic ad-
junct as one part of an ERP.
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Opioids
The primary objective of the practitioner should be to
minimize the use of opioids wherever possible. Under
general anesthesia, patients are unconscious and do not
perceive pain. Although there is no pain perception,
surgery-induced activation of nociceptive reflex arcs has
hemodynamic consequences. Using opioids to reduce
the hemodynamic changes should be resisted as much
as possible, as hyperalgesia can develop acutely and
opioid-related side effects can occur at very low doses
(Hayhurst and Durieux 2016; Rathmell et al. 2006). Con-
trol of blood pressure and heart rate at intubation and
during surgery by beta-blockers, calcium channel
blockers, or lidocaine should be encouraged rather than
using opioids without a specific indication other than
intraoperative tachycardia or hypertension. As noted
above, replacing opioids with any non-opioid analgesic
or esmolol intraoperatively leads to less opioid being re-
quired in the PACU and often out to 24 h postopera-
tively in some laparoscopic surgery (Lee and Lee 2010;
Collard et al. 2007; Pranevicius and Pranevicius 2009). If
an opioid must be used, we recommend using small
doses of short-acting opioids such as alfentanil or
fentanyl.
Q4: How does pain vary based upon the surgical
approach in colorectal surgery?
Statement: The degree of pain after CRS will vary based
upon the surgical approach and planned analgesic solu-
tions will take this into account.
As the pain experience is different based on the
procedure, so too should the analgesia be procedure
and patient-specific. While not considered an anal-
gesic strategy, a number of studies have reported re-
duction in short-term pain, analgesic use, and more
rapid recovery of bowel function with laparoscopic
surgery versus open (Reza et al. 2006). The difference
in the pain experience between laparoscopic and open
approaches for operations may be limited to the
short-term management, as pain reported at 1 to
3 months did not differ between approaches (Reza et
al. 2006; Lourenco et al. 2008; Murray et al. 2006).
One important difference in laparoscopic CRS com-
pared to other laparoscopic procedures is the place-
ment of ports and size and placement of the largest
incision. Different from a gallbladder or a morselized
uterus, the colorectal specimens have to be removed
intact. Often, the bowel anastomosis is most easily or-
ganized extra-corporeally as well. This longer incision,
for specimen extraction and anastomosis, may be um-
bilical, transverse, upper or lower midline, or Pfan-
nenstiel. Overall, the chosen approach/incision and its
length certainly impact the best choice of analgesia
plan. Additionally, as the surgeon can occasionally
choose to vary approach intraoperatively as needed, a sec-
ondary plan should be in place for these circumstances.
Q5: What is the role of education in achieving optimal
analgesia after CRS?
Statement: Patient and family education throughout the
entire perioperative period is essential for achieving opti-
mal analgesia after CRS.
Optimal analgesia cannot be achieved without involv-
ing the most important factor, the patient, starting with
partnership, education, shared decision making, and
well-coordinated transitions of care (Manary et al. 2013).
Because pain is a complex and subjective biopsychoso-
cial experience, management of patient expectations and
education regarding realistic goals of pain treatment is
crucial to an effective pharmacological approach. Thus,
we recommend this includes analgesic treatment plans
and goals for postoperative pain management (Wood
2010; Oshodi 2007a; Oshodi 2007b). While the exact
timing, methods, and content of preoperative education
will be locally determined, we suggest that patient edu-
cation and expectation management occur through all
phases of care and include information about choice and
risks of analgesic technique, goals of analgesia, antici-
pated patient participation in recovery activities, and
non-pharmacological methods that can be employed to
reduce reliance on rescue analgesics (see Fig. 2) (Chou
et al. 2016b; O’Connor et al. 2014). Important consider-
ations include information about analgesia methods and
goals in patient-friendly print materials with appropriate
literacy levels (Ihedioha et al. 2013).
Additionally, as some patients will have had surgery
prior to the institution of an ERP, and as ERPs for CRS
typically utilize a multimodal analgesic approach to
minimize perioperative opioid use in an attempt to de-
crease opioid-related side effects, it is important to discuss
surgical history and pain management expectations based
on prior interventions and experiences. This is especially
true as some ERPs may attempt to avoid IV-PCA opioids
and thus use opioids only as PRN rescue, as recom-
mended in Part 2 (McEvoy et al. 2016; Wu et al. 2015). It
should be explained to patients that opioids still remain
an important option for postoperative pain management;
however, the precise role of opioids in ERPs is currently
not clearly defined, and expectations surrounding their
use in the perioperative, along with the goals of delivering
optimal analgesia, should be clarified preoperatively.
Summary and future directions
Delivering optimal analgesia is a key component of
enhanced recovery pathways for colorectal surgery.
Following our literature search and modified Delphi
process, we conclude that the number of published stud-
ies specifically examining analgesia for CRS within an
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ERP with good documented compliance is limited. We
have used data from these studies and extrapolated data
from other published studies on analgesia for CRS to
recommend a best-practice approach for creating a peri-
operative pain management plan that includes a number
of key components (see Table 1).
There are many ways to achieve analgesia for patients
undergoing CRS. The technique of choice will depend
on which surgical procedure is performed and by which
approach (laparoscopic, robotic assisted, or open). Add-
itionally, patient factors and availability of experienced
providers, training, and equipment within a hospital will
also determine which technique can be utilized. A multi-
faceted approach to pain management is necessary to re-
store postoperative function as rapidly as possible to
baseline. Importantly, this must facilitate mobility and
respiratory function, enable early oral intake of diet and
hydration, avoid ileus, promote normal sleep patterns,
and minimize the common side effects of opiate-based
analgesia. We have produced a consensus outlining a ra-
tionale and key components for approaching pain man-
agement in an ERP for CRS. Part 2 of this series will
discuss the postoperative components of an optimal an-
algesia care plan for CRS.
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